Michelle A. Lane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michelle A. Lane has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Sarah J. Bailey
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
3 shared publications Elana W. Wilen
Department of Pharmacology, Weill Cornell Medical College, Cornell University, 1300 York Avenue, New York, NY 10021, United States
1 shared publicationFadila Derguini
Institut de recherché Pierre Fabre, Unité CNRS-Pierre Fabre 1973, 3 rue Ariane, Parc Technologique du Canal, 31527 Ramonville, France
1 shared publication- Francisco Gonzalez-Lima
Department of Psychology and Institute for Neuroscience, University of Texas at Austin, Austin, TX 78712, USA
1 shared publication - Jason Shumake
The University of Texas at Austin
1 shared publication Juliana Xu
Department of Pharmacology, Weill Cornell Medical College, Cornell University, 1300 York Avenue, New York, NY 10021, United States
1 shared publication
Latest Publications
- 1 March 2008
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 233 (3) , 251-258
Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
Vitamin A and its derivatives, the retinoids, have long been studied for their ability to alter central nervous system (CNS) development. Increasingly, it is recognized that sufficient levels of retinoids may also be required for adult CNS function. However, excess dietary vitamin A, due to the consumption of supplements or foods rich in vitamin A, has been reported to induce psychosis. In addition, 13- cis-retinoic acid (13- cis-RA, isotretinoin), the active ingredient in the acne treatment Accutane, has been reported to cause adverse psychiatric events, including depression and suicidal ideation. Nevertheless, epidemiological studies have reported no consistent link between Accutane use and clinical depression in humans. Using an animal model, we have recently shown that 13- cis-RA induces an increase in depression-related behavior. Impairments in spatial learning and memory have also been demonstrated following 13- cis-RA treatment in mice. This review focuses on the behavioral and possible cellular effects of retinoid deficiency or excess in the adult brain in relation to altered mood. Specifically, we discuss the effect of retinoids on depression-related behaviors and whether norepinephrinergic, dopaminergic, or serotonergic neurotransmitter systems may be impaired. In addition, we consider the evidence that adult neurogenesis, a process implicated in the pathophysiology of depression, is reduced by retinoid signaling. We suggest that 13- cis-RA treatment may induce depression-related behaviors by decreasing adult neurogenesis and/or altering the expression of components of serotonergic neurotransmitter system, thereby leading to impaired serotonin signaling.
- 1 March 2008
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 233 (3) , 251-258
Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
Vitamin A and its derivatives, the retinoids, have long been studied for their ability to alter central nervous system (CNS) development. Increasingly, it is recognized that sufficient levels of retinoids may also be required for adult CNS function. However, excess dietary vitamin A, due to the consumption of supplements or foods rich in vitamin A, has been reported to induce psychosis. In addition, 13- cis-retinoic acid (13- cis-RA, isotretinoin), the active ingredient in the acne treatment Accutane, has been reported to cause adverse psychiatric events, including depression and suicidal ideation. Nevertheless, epidemiological studies have reported no consistent link between Accutane use and clinical depression in humans. Using an animal model, we have recently shown that 13- cis-RA induces an increase in depression-related behavior. Impairments in spatial learning and memory have also been demonstrated following 13- cis-RA treatment in mice. This review focuses on the behavioral and possible cellular effects of retinoid deficiency or excess in the adult brain in relation to altered mood. Specifically, we discuss the effect of retinoids on depression-related behaviors and whether norepinephrinergic, dopaminergic, or serotonergic neurotransmitter systems may be impaired. In addition, we consider the evidence that adult neurogenesis, a process implicated in the pathophysiology of depression, is reduced by retinoid signaling. We suggest that 13- cis-RA treatment may induce depression-related behaviors by decreasing adult neurogenesis and/or altering the expression of components of serotonergic neurotransmitter system, thereby leading to impaired serotonin signaling.
- 2 January 2008
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 280 (1-2) , 63-74
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol
- 2 January 2008
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 280 (1-2) , 63-74
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol
- 4 January 2006
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 31 (9) , 1919-1927
Chronic Administration of 13-Cis-Retinoic Acid Increases Depression-Related Behavior in Mice
Retinoid signaling plays a well-established role in neuronal differentiation, neurite outgrowth, and the patterning of the anteroposterior axis of the developing neural tube. However, there is increasing evidence that nutritional vitamin A status and retinoid signaling play an important role in the function of the adult brain. 13-Cis-retinoic acid (13-cis-RA) (isotretinoin or Accutane), a synthetic retinoid that is an effective oral treatment for severe nodular acne, has been linked with depression and suicide in patients. The purpose of this study was to test the hypothesis that chronic administration of 13-cis-RA would lead to depression-related behaviors in mice. Young, adult male mice received 13-cis-RA (1 mg/kg) by daily intraperitoneal injection for 6 weeks. This treatment paradigm produced plasma levels of 13-cis-RA that are comparable to those reported in human patients taking Accutane. In both the forced swim test and the tail suspension test, we found that 13-cis-RA-treated mice spent significantly more time immobile compared to vehicle-treated controls. In the open field test, there was no change in anxiety-related behavior in 13-cis-RA-treated mice. Furthermore, chronic administration of 13-cis-RA did not impair locomotion in either the open field or the rotarod test. Taken together, these results suggest that administration of 13-cis-RA increases depression-related behaviors in mice.
- 4 January 2006
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 31 (9) , 1919-1927
Chronic Administration of 13-Cis-Retinoic Acid Increases Depression-Related Behavior in Mice
Retinoid signaling plays a well-established role in neuronal differentiation, neurite outgrowth, and the patterning of the anteroposterior axis of the developing neural tube. However, there is increasing evidence that nutritional vitamin A status and retinoid signaling play an important role in the function of the adult brain. 13-Cis-retinoic acid (13-cis-RA) (isotretinoin or Accutane), a synthetic retinoid that is an effective oral treatment for severe nodular acne, has been linked with depression and suicide in patients. The purpose of this study was to test the hypothesis that chronic administration of 13-cis-RA would lead to depression-related behaviors in mice. Young, adult male mice received 13-cis-RA (1 mg/kg) by daily intraperitoneal injection for 6 weeks. This treatment paradigm produced plasma levels of 13-cis-RA that are comparable to those reported in human patients taking Accutane. In both the forced swim test and the tail suspension test, we found that 13-cis-RA-treated mice spent significantly more time immobile compared to vehicle-treated controls. In the open field test, there was no change in anxiety-related behavior in 13-cis-RA-treated mice. Furthermore, chronic administration of 13-cis-RA did not impair locomotion in either the open field or the rotarod test. Taken together, these results suggest that administration of 13-cis-RA increases depression-related behaviors in mice.
- 1 March 2005
- Published by Elsevier in Progress in Neurobiology
- Vol. 75 (4) , 275-293
Role of retinoid signalling in the adult brain
- 1 March 2005
- Published by Elsevier in Progress in Neurobiology
- Vol. 75 (4) , 275-293
Role of retinoid signalling in the adult brain